D.
Maciejewska
*a,
J.
Żabiński
a,
M.
Rezler
a,
P.
Kaźmierczak
a,
M. S.
Collins
bc,
L.
Ficker
bc and
M. T.
Cushion
*bc
aDepartment of Organic Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Street, 02-097 Warsaw, Poland. E-mail: dmaciejewska@wum.edu.pl
bDivision of Infectious Diseases, Department of Internal Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA. E-mail: cushionmt@ucmail.uc.edu
cCincinnati Veterans Affairs Medical Center, 3200 Vine Street, Cincinnati, OH 45220, USA
First published on 7th November 2017
Correction for ‘Development of highly active anti-Pneumocystis bisbenzamidines: insight into the influence of selected substituents on the in vitro activity’ by D. Maciejewska et al., Med. Chem. Commun., 2017, 8, 2003–2011.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2017 |